Search for Clinical Trial Results
Prostatic Hyperplasia - 40 Studies Found
Status | Study |
Completed |
Study Name: Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects Condition: Prostatic Hyperplasia Date: 2006-08-24 Interventions:
|
Recruiting |
Study Name: Prostate Embolization for Benign Prostatic Hyperplasia Condition: Benign Prostatic Hyperplasia Date: 2013-08-14 Interventions:
|
Completed |
Study Name: Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic Hyperplasia Condition: Prostatic Hyperplasia Date: 2011-04-07 Interventions:
|
Completed |
Study Name: A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia (BPH) Condition: Prostatic Hyperplasia Date: 2009-10-28 Interventions: Drug: Doxazosin mesylate GITS Doxazosin mesylate GITS 4mg to 8mg once daily |
Terminated |
Study Name: Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia Condition: Prostatic Hyperplasia Date: 2012-06-28 Interventions: Drug: Dutasteride/Tamsulosin 0.5 mg dutasteride/ 0.4 mg tamsulosin once daily for the duration of 180 da |
Terminated |
Study Name: An Observational Study of Dutasteride and Alpha-blocker Combination Therapy in Men With Symptomatic Benign Prostatic Hyperplasia and PSA Level Over 4 ng/mL Condition: Benign Prostatic Hyperplasia Date: 2011-05-10 |
Completed |
Study Name: A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo Condition: Benign Prostatic Hyperplasia (BPH) Date: 2005-09-14 Interventions:
|
Completed |
Study Name: The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months Condition: Benign Prostatic Hyperplasia Date: 2005-09-14 Interventions: Drug: Silodosin 8 mg daily Other Name: Rapaflo |
Completed |
Study Name: Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia Condition: Prostatic Hyperplasia Date: 2014-01-23 Interventions:
|
Active, not recruiting |
Study Name: Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyperplasia Condition: Benign Prostatic Hyperplasia Date: 2014-07-29 Interventions: Drug: Embozene Microspheres Intraarterial application |